Effect of Metal Artifacts Reduction Orotocols and Electric Potential Difference on Metal Artifacts in Cone Beam Computed Tomography (DTA)

January 21, 2020 updated by: Marina Salib, Cairo University

Effect of Metal Artifacts Reduction Protocols and Tube Potential Difference on Metal Artifacts in Cone Beam Computed

The effect of metal artifacts reduction protocols and tube potential difference on the metallic artifacts in cone beam computed tomography

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Our study is a quantitative as well as a qualitative assessment of the metal artifacts in the CBCT images in a bio models with multiple adjacent dental implants and single isolated implants , while using different MAR protocols inherited in the CBCT soft ware , as well as change in the tube potential difference of the CBCT unit

Study Type

Interventional

Enrollment (Actual)

2

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Giza
      • Cairo, Giza, Egypt, 12511
        • Marina Salib

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • bio models of a lower jaw Titanium implants Porcelain fused to metal crowns

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Tube Potential difference
Different kVp values of the CBCT machine 70, 80 ,90 kVp
CBCT scanning
Experimental: MAR tool
MAR option in the software off and on
CBCT scanning

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dental implant linear measurement
Time Frame: 1 month
The implant length and width in millimeters will be assessed in the presence of the artifacts with and without the activation of the MAR tool of the CBCT soft ware, also change in the potential difference will be done with and without the activation of MAR tool
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bone- implant interphase
Time Frame: 1 month
Qualitative assessment if bone - implant interphase, will be either zero or 1 zero indicate that bone implant interphase cannot be assessed , one indicate that the bone implant interphase can be assessed
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Mushira M Dahba, Doctorate, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 10, 2018

Primary Completion (Actual)

October 30, 2018

Study Completion (Anticipated)

December 10, 2021

Study Registration Dates

First Submitted

October 12, 2018

First Submitted That Met QC Criteria

October 30, 2018

First Posted (Actual)

November 1, 2018

Study Record Updates

Last Update Posted (Actual)

January 23, 2020

Last Update Submitted That Met QC Criteria

January 21, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • RAD

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metal Artifacts

Clinical Trials on CBCT radiation

3
Subscribe